REPUBLIC HC(08357.HK)擬折價10.5%配股 最多籌2094.56萬港元
格隆匯8月20日丨REPUBLIC HC(08357.HK)公佈,於2021年8月20日,公司擬透過配售代理向不少於六名承配人發行最多1.04億股,佔經擴大後公司股份約16.67%。每股配售價為0.2014港元,較8月20日收市價折讓約10.5%。
假設1.04億股配售股份獲配售代理全數成功配售,則配售事項的估計所得款項總額及所得款項淨額將分別約為2094.56萬港元及2039.67萬港元。公司擬將所得款項淨額用於以下用途:(a)約60%將用於日後拓展集團的現有業務及於日後出現適當機會時收購及/或投資可發揮集團競爭優勢的業務;及(b)約40%將用於擴充集團的營運資金,以用於業務營運。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.